Trial Profile
Umirolimus (biolimus)-eluting stent in coronary bifurcation lesions compared with everolimus-eluting stent
Status:
Completed
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 28 Oct 2015
Price :
$35
*
At a glance
- Drugs Everolimus (Primary) ; Umirolimus (Primary)
- Indications Coronary artery disease; Coronary artery restenosis
- Focus Therapeutic Use
- 28 Oct 2015 New trial record
- 02 Sep 2015 Results presented at ESC Congress 2015: Annual Congress of the European Society of Cardiology.